SNT
GHDX

Security National Trust’s Genomic Health, Inc. GHDX Stock Holding History

Security National Trust’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-300
Closed -$8K – 554
2014
Q2 		$8K Hold
300
– – ﹤0.01% 434
2014
Q1 		$8K Hold
300
– – ﹤0.01% 432
2013
Q4 		$9K Buy
+300
New +$9.52K ﹤0.01% 425

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Security National Trust's GHDX Position: Q3 2014 in Review

Security National Trust sold out of Genomic Health, Inc. (GHDX) in Q3 2014, closing a stake of 300 shares — an estimated $8K sold.

Security National Trust first reported a position in GHDX in Q4 2013 and held it in 3 quarters. The position peaked at $9K in Q4 2013. 107 funds tracked by Wall St. Rank hold GHDX as of Q3 2014.

  • Security National Trust reported no remaining Genomic Health, Inc. position as of Q3 2014 after selling out during the quarter.
  • Security National Trust sold 300 Genomic Health, Inc. shares in Q3 2014, an estimated $8K.
  • Security National Trust first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 3 quarters.
  • Security National Trust's Genomic Health, Inc. position peaked at $9K in Q4 2013.
  • 107 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2014.

Based on Security National Trust's 13F filing for Q3 2014, filed 5 Nov 2014.